DNA Capital portfolio

DNA Capital has 2 portfolio companies on record at Recent Funding.

Website: dnacapital.com.

Type: Venture capital.

Portfolio on Recent Funding: 2.

Deals, last 12 months: 0.

About this page

It is a venture capital firm based in São Paulo, BR, founded in 2025. By category, its portfolio leans toward Health and bio (2) and Consumer and social (1).

About DNA Capital

Firm type: Venture capital.

Headquarters: São Paulo, BR.

Founded: 2025.

Stages: Seed, Series A, Series B, Growth, Late Stage.

Sectors: Biotech, Digital Health, Healthtech.

Check size: $100K to $5M.

Leads rounds: Yes.

Portfolio companies: 10.

Exits: 0.

Rounds led: 0.

What DNA Capital invests in

Health and bio · 2 · 100%
Consumer and social · 1 · 50%

DNA Capital portfolio companies

RReemabacker
CCambridge Epigenetixbacker

Company	Round with DNA Capital	Total raised	Latest raise
RReema Health and bio	backer	$19M	Dec 2, 2025 Series B+
CCambridge Epigenetix Health and bio	backer	$93.5M	Nov 2, 2021 Series B+

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Portfolio companies are the companies on Recent Funding with a round that lists DNA Capital, which is a subset of its real portfolio. API: /api/v1/investors/dna-capital (get a free API key). More: the most active VC firms and new venture capital funds.